Centene Corp
NYSE:CNC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
57.46
80.41
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Centene Corp
Non-Reccuring Items
Centene Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Centene Corp
NYSE:CNC
|
Non-Reccuring Items
-$226m
|
CAGR 3-Years
47%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
||
UnitedHealth Group Inc
NYSE:UNH
|
Non-Reccuring Items
-$8.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Molina Healthcare Inc
NYSE:MOH
|
Non-Reccuring Items
-$3m
|
CAGR 3-Years
64%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
||
Humana Inc
NYSE:HUM
|
Non-Reccuring Items
-$696m
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Healthequity Inc
NASDAQ:HQY
|
Non-Reccuring Items
-$8.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
||
Elevance Health Inc
NYSE:ELV
|
Non-Reccuring Items
$179m
|
CAGR 3-Years
153%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Centene Corp
Glance View
Centene Corporation is a prominent player in the healthcare sector, known for its innovative approach to delivering affordable and accessible health insurance solutions. Founded in 1984, this Fortune 500 company has grown significantly, primarily focusing on government-sponsored healthcare programs, including Medicaid and Medicare. Centene's diverse health plans serve a wide demographic, including low-income families, the aging population, and those with complex healthcare needs. Through strategic acquisitions, robust technology investments, and a commitment to community-based care, Centene has positioned itself as a key provider in the rapidly evolving healthcare landscape. What sets Centene apart is its relentless focus on integrated healthcare solutions and patient-centric services. By leveraging data analytics and personalized care strategies, the company aims to improve health outcomes while managing costs effectively. In recent years, Centene has expanded its footprint by acquiring organizations that enhance its capabilities and market presence. This growth strategy not only strengthens its service offerings but also fortifies its competitive edge. For investors, Centene represents a compelling opportunity, combining steady revenue growth, a commitment to innovation, and a mission-driven approach that aims to bridge the gap in healthcare access for underserved populations.
See Also
What is Centene Corp's Non-Reccuring Items?
Non-Reccuring Items
-226m
USD
Based on the financial report for Sep 30, 2024, Centene Corp's Non-Reccuring Items amounts to -226m USD.
What is Centene Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
7%
Over the last year, the Non-Reccuring Items growth was 81%. The average annual Non-Reccuring Items growth rates for Centene Corp have been 47% over the past three years , 7% over the past five years .